SYMBOL:

    Up to 100 tickers separated by a space
Do Not Trade on Beta Ratings - these are in Testing - and purposely being Randomized - Repeat - Do Not Trade on Ratings - In Testing - Thank you!
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ANTHERA PHARMACEUTICALS
(NQNM:ANTH Last Sale: .6 -.0069)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ANTH : $.6)
$13 million Market Cap at May 24, 2013
Loss Expected for 2013; Biomedics SubIndustry priced at 21.9X PE
Biomedics SubIndustry down < .07%> / Health Industry down < .07> Today

Research Report Earnings Snapshot - Last 05/13/13
Annual Reports


Developing anti-inflammatory therapeutics for cardiovascular diseases and lupus. IPO at $7 February 26, 2010. Raised $42 million, selling 6 million shares, 28% of the outstanding. Lead Manager: Deutsche Bank.
Historical Charts    Technical Analysis    IntraDay Charts

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ANTH $.6 $.6069 -.0069 -1.1 $.581 $.62 480,950 $.4901 $3.21 21,587
Capitalization
Earnings Summary (4024261)
Annual EarningsQuarterly Earnings
 
 
Earnings
Growth
Prior
Surprise
Estimate
 
2010
$( 1.95)a
 
 
-59%
$( 1.23)e
 
2011
$( 2.53)a
-30%
vs. $( 1.95)a
-24%
$( 2.04)e
Last
2012
$( 1.22)a
+52%
vs. $( 2.53)a
-3%
$( 1.18)e
Current
2013
$( 0.17)e
+86%
vs. $( 1.22)a
 
$( 0.17)e
Next
2014
$( 0.25)e
-47%
vs. $( 0.17)e
 
$( 0.25)e
Last
Q4-2012
$( 0.11)a
+85%
vs. $( 0.71)a
+31%
$( 0.16)e
Current
Q1-2013
$( 0.06)a
+88%
vs. $( 0.51)a
+25%
$( 0.08)e
Next
Q2-2013
$( 0.08)e
 
 
 
$( 0.08)e
Common Stock $12,952
Consensus Estimate
2013 Earnings ( -$3,670)

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2013 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex